6272 related articles for article (PubMed ID: 3498854)
61. Specific cytotoxicity of a human immunoglobulin-directed Fab'-ricin A chain conjugate.
Raso V; Griffin T
J Immunol; 1980 Dec; 125(6):2610-6. PubMed ID: 7430640
[TBL] [Abstract][Full Text] [Related]
62. Potentiation of antitumor immunotoxins by liposomal monensin.
Griffin T; Rybak ME; Recht L; Singh M; Salimi A; Raso V
J Natl Cancer Inst; 1993 Feb; 85(4):292-8. PubMed ID: 8426373
[TBL] [Abstract][Full Text] [Related]
63. Immunotoxins to the murine transferrin receptor: intracavitary therapy of mice bearing syngeneic peritoneal tumors.
Bjorn MJ; Groetsema G
Cancer Res; 1987 Dec; 47(24 Pt 1):6639-45. PubMed ID: 3499979
[TBL] [Abstract][Full Text] [Related]
64. Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin.
Wawrzynczak EJ; Watson GJ; Cumber AJ; Henry RV; Parnell GD; Rieber EP; Thorpe PE
Cancer Immunol Immunother; 1991; 32(5):289-95. PubMed ID: 1998970
[TBL] [Abstract][Full Text] [Related]
65. The anti-CD20 antibody rituximab augments the immunospecific therapeutic effectiveness of an anti-CD19 immunotoxin directed against human B-cell lymphoma.
Flavell DJ; Warnes SL; Bryson CJ; Field SA; Noss AL; Packham G; Flavell SU
Br J Haematol; 2006 Jul; 134(2):157-70. PubMed ID: 16771848
[TBL] [Abstract][Full Text] [Related]
66. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
Chari RV
Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
[TBL] [Abstract][Full Text] [Related]
67. Enhancement of ricin toxin A chain immunotoxin activity: synthesis, ionophoretic ability, and in vitro activity of monensin derivatives.
Dosio F; Franceschi A; Ceruti M; Brusa P; Cattel L; Colombatti M
Biochem Pharmacol; 1996 Jul; 52(1):157-66. PubMed ID: 8678901
[TBL] [Abstract][Full Text] [Related]
68. Carcinoembryonic antigen-targeted selective gene therapy for gastric cancer through FZ33 fiber-modified adenovirus vectors.
Tanaka T; Huang J; Hirai S; Kuroki M; Kuroki M; Watanabe N; Tomihara K; Kato K; Hamada H
Clin Cancer Res; 2006 Jun; 12(12):3803-13. PubMed ID: 16778108
[TBL] [Abstract][Full Text] [Related]
69. [Cytotoxicity of a conjugate of ricin A-chain and monoclonal anti-allotypic antibody].
Rachmanova VA; Tonevitskiĭ AG; Cherapakhin VV; Bobreneva RA
Biull Eksp Biol Med; 1988 May; 105(5):568-70. PubMed ID: 3132992
[TBL] [Abstract][Full Text] [Related]
70. Selective in vitro inhibition of an antibody response to purified acetylcholine receptor by using anti-idiotypic antibodies coupled to the A chain of ricin.
DeShambo RM; Krolick KA
J Immunol; 1986 Nov; 137(10):3135-9. PubMed ID: 3490511
[TBL] [Abstract][Full Text] [Related]
71. E1A, E1B double-restricted replicative adenovirus at low dose greatly augments tumor-specific suicide gene therapy for gallbladder cancer.
Fukuda K; Abei M; Ugai H; Kawashima R; Seo E; Wakayama M; Murata T; Endo S; Hamada H; Hyodo I; Yokoyama KK
Cancer Gene Ther; 2009 Feb; 16(2):126-36. PubMed ID: 18818710
[TBL] [Abstract][Full Text] [Related]
72. Expression of HER2 in human gastric cancer cells directly correlates with antitumor activity of a recombinant disulfide-stabilized anti-HER2 immunotoxin.
Shinohara H; Morita S; Kawai M; Miyamoto A; Sonoda T; Pastan I; Tanigawa N
J Surg Res; 2002 Feb; 102(2):169-77. PubMed ID: 11796015
[TBL] [Abstract][Full Text] [Related]
73. Specific inhibition of in vitro lymphocyte transformation by an anti-pan T cell (gp67) ricin A chain immunotoxin.
Kernan NA; Knowles RW; Burns MJ; Broxmeyer HE; Lu L; Lee HM; Kawahata RT; Scannon PJ; Dupont B
J Immunol; 1984 Jul; 133(1):137-46. PubMed ID: 6609971
[TBL] [Abstract][Full Text] [Related]
74. Redirected T-cell cytotoxicity to epithelial cell adhesion molecule-overexpressing adenocarcinomas by a novel recombinant antibody, E3Bi, in vitro and in an animal model.
Ren-Heidenreich L; Davol PA; Kouttab NM; Elfenbein GJ; Lum LG
Cancer; 2004 Mar; 100(5):1095-103. PubMed ID: 14983507
[TBL] [Abstract][Full Text] [Related]
75. Rapid screening with indirect immunotoxin for monoclonal antibodies against human small cell lung cancer.
Weltman JK; Pedroso P; Johnson SA; Davignon D; Fast LD; Leone LA
Cancer Res; 1987 Nov; 47(21):5552-6. PubMed ID: 2822229
[TBL] [Abstract][Full Text] [Related]
76. Effect of a monoclonal anti-carcinoembryonic antigen antibody-ricin A-chain conjugate on human carcinoembryonic antigen-producing tumor cells.
Watanabe Y; Miyazaki H; Osawa T
J Pharmacobiodyn; 1984 Aug; 7(8):593-603. PubMed ID: 6512681
[TBL] [Abstract][Full Text] [Related]
77. In vitro cytotoxicity of the conjugate adriamycin with anti-sarcoma monoclonal antibody 19-24.
Mohamed G; Kuzmanoff KM; Stastny JJ; Das Gupta TK
Anticancer Res; 1992; 12(2):529-32. PubMed ID: 1580569
[TBL] [Abstract][Full Text] [Related]
78. A carcinoembryonic antigen-directed immunotoxin built by linking a monoclonal antibody to a hemolytic toxin.
Avila AD; Mateo de Acosta C; Lage A
Int J Cancer; 1989 May; 43(5):926-9. PubMed ID: 2785509
[TBL] [Abstract][Full Text] [Related]
79. Mediation of reduction of spontaneous and experimental pulmonary metastases by ricin A-chain immunotoxin 45-2D9-RTA with potentiation by systemic monensin in mice.
Roth JA; Ames RS; Fry K; Lee HM; Scannon PJ
Cancer Res; 1988 Jun; 48(12):3496-501. PubMed ID: 3259469
[TBL] [Abstract][Full Text] [Related]
80. Potentiation of a weakly active ricin A chain immunotoxin recognizing the neural cell adhesion molecule.
Derbyshire EJ; Stahel RA; Wawrzynczak EJ
Clin Exp Immunol; 1992 Sep; 89(3):336-40. PubMed ID: 1325302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
